当前蛋白身份:P08238 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1QZ2 Crystal Structure of FKBP52 C-terminal Domain complex with the C-terminal peptide MEEVD of Hsp90 提交 2003-09-15 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 G 719–723(5 aa)
链 H 719–723(5 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;291 K;Sodium Citrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K
分辨率 3.00 Å R-free 0.287
1UYM Human Hsp90-beta with PU3 (9-Butyl-8(3,4,5-trimethoxy-benzyl)-9H-purin-6-ylamine) 提交 2004-03-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–220(220 aa) 片段:N-TERMINAL DOMAIN, RESIDUES 1-220
未记录 PU3 9-BUTYL-8-(3,4,5-TRIMETHOXYBENZYL)-9H-PURIN-6-AMINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;25% PEG MME 2000, 0.1M NA CACODYLATE, PH6.5, 0.2M MGCL2., pH 6.50
分辨率 2.45 Å R-free 0.294
3FWV Crystal Structure of a Redesigned TPR Protein, T-MOD(VMY), in Complex with MEEVF Peptide 提交 2009-01-19 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 719–723(5 aa) 片段:C-terminal residues
非标准单体:是(mmCIF未提供具体位点) NI NICKEL (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;100 mM Tris pH 8.5, 30% PEG MME 2000, 5-10 mM NiCl2, 10% xylitol, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.20 Å R-free 0.244
3FWV Crystal Structure of a Redesigned TPR Protein, T-MOD(VMY), in Complex with MEEVF Peptide 提交 2009-01-19 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 719–723(5 aa) 片段:C-terminal residues
非标准单体:是(mmCIF未提供具体位点) NI NICKEL (II) ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;100 mM Tris pH 8.5, 30% PEG MME 2000, 5-10 mM NiCl2, 10% xylitol, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.20 Å R-free 0.244
3NMQ Hsp90b N-terminal domain in complex with EC44, a pyrrolo-pyrimidine methoxypyridine inhibitor 提交 2010-06-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–223(223 aa) 片段:N-terminal domain (UNP residues 1-223)
未记录 7PP 5-{2-amino-4-chloro-7-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl}-2-methylpent-4-yn-2 -ol × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1M Na Cacodylate, 20% PEG 2000 MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.20 Å R-free 0.267
3PRY Crystal structure of the middle domain of human HSP90-beta refined at 2.3 A resolution 提交 2010-11-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 284–543(260 aa) 片段:middle domain (UNP residues 284-543)
未记录 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293.15 K;25.5% PEG3350, 0.17 M ammonium sulfate, 15% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
分辨率 2.28 Å R-free 0.217
3PRY Crystal structure of the middle domain of human HSP90-beta refined at 2.3 A resolution 提交 2010-11-30 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 284–543(260 aa) 片段:middle domain (UNP residues 284-543)
未记录 SO4 SULFATE ION × 1 GOL GLYCEROL × 1 EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293.15 K;25.5% PEG3350, 0.17 M ammonium sulfate, 15% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
分辨率 2.28 Å R-free 0.217
3PRY Crystal structure of the middle domain of human HSP90-beta refined at 2.3 A resolution 提交 2010-11-30 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 284–543(260 aa) 片段:middle domain (UNP residues 284-543)
未记录 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293.15 K;25.5% PEG3350, 0.17 M ammonium sulfate, 15% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
分辨率 2.28 Å R-free 0.217
5FWK Atomic cryoEM structure of Hsp90-Cdc37-Cdk4 complex 提交 2016-02-17 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–724(724 aa) 片段:FULL LENGTH
链 B 1–724(724 aa) 片段:FULL LENGTH
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 MG MAGNESIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 20MM TRIS-HCL (PH 7.5), 150 MM NACL, 10 MM KCL, 10 MM MGCL2, 20 MM NA2MOO4, 2MM DTT, 0.085MM DDM;pH 7.5;20MM TRIS-HCL (PH 7.5), 150 MM NACL, 10 MM KCL, 10 MM MGCL2, 20 MM NA2MOO4, 2MM DTT, 0.085MM DDM
cryo-EM玻璃化条件 冷冻剂 ETHANE;LIQUID ETHANE
分辨率 3.90 Å
5FWL Atomic cryoEM structure of Hsp90-Cdc37-Cdk4 complex 提交 2016-02-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 MG MAGNESIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 20MM TRIS-HCL, 150 MM NACL, 10MM KCL, 10MM MGCL2, 20MM NA2MOO4, 2MM DTT, 0.085MM DDM;pH 7.5;20MM TRIS-HCL, 150 MM NACL, 10MM KCL, 10MM MGCL2, 20MM NA2MOO4, 2MM DTT, 0.085MM DDM
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 9.00 Å
5FWM Atomic cryoEM structure of Hsp90-Cdc37-Cdk4 complex 提交 2016-02-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 MG MAGNESIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 20MM TRIS-HCL (PH 7.5), 150 MM NACL, 10 MM KCL, 10 MM MGCL2, 20 MM NA2MOO4, 2MM DTT, 0.085MM DDM;pH 7.5;20MM TRIS-HCL (PH 7.5), 150 MM NACL, 10 MM KCL, 10 MM MGCL2, 20 MM NA2MOO4, 2MM DTT, 0.085MM DDM
cryo-EM玻璃化条件 冷冻剂 ETHANE;LIQUID ETHANE
分辨率 8.00 Å
5FWP Atomic cryoEM structure of Hsp90-Cdc37-Cdk4 complex 提交 2016-02-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 MG MAGNESIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5;20mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM KCl, 10 mM MgCl2, 20 mM Na2MoO4, 2mM DTT, 0.085mM DDM
cryo-EM玻璃化条件 Single blot from 4 to 6 seconds, at 20C;95 K;冷冻剂 ETHANE;LIQUID ETHANE
分辨率 7.20 Å
5UC4 Hsp90b N-terminal domain with inhibitors 提交 2016-12-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–218(218 aa) 片段:N-terminal domain (UNP residues 1-218)
未记录 83S 5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylbenzaldehyde × 1 GOL GLYCEROL × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.05 Å R-free 0.207
5UC4 Hsp90b N-terminal domain with inhibitors 提交 2016-12-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–218(218 aa) 片段:N-terminal domain (UNP residues 1-218)
未记录 83S 5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylbenzaldehyde × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.05 Å R-free 0.207
5UC4 Hsp90b N-terminal domain with inhibitors 提交 2016-12-21 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–218(218 aa) 片段:N-terminal domain (UNP residues 1-218)
未记录 83S 5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylbenzaldehyde × 1 GOL GLYCEROL × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.05 Å R-free 0.207
5UC4 Hsp90b N-terminal domain with inhibitors 提交 2016-12-21 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–218(218 aa) 片段:N-terminal domain (UNP residues 1-218)
未记录 83S 5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylbenzaldehyde × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.05 Å R-free 0.207
5UCH Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–218(218 aa) 片段:UNP residues 1-218
未记录 871 2-(5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylphenyl)acetonitrile × 1 GOL GLYCEROL × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.65 Å R-free 0.226
5UCH Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–218(218 aa) 片段:UNP residues 1-218
未记录 871 2-(5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylphenyl)acetonitrile × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.65 Å R-free 0.226
5UCH Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–218(218 aa) 片段:UNP residues 1-218
未记录 871 2-(5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylphenyl)acetonitrile × 1 GOL GLYCEROL × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.65 Å R-free 0.226
5UCH Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–218(218 aa) 片段:UNP residues 1-218
未记录 871 2-(5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylphenyl)acetonitrile × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.65 Å R-free 0.226
5UCI Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–218(218 aa) 片段:UNP residues 1-218
未记录 874 (2,4-Dihydroxy-3-(hydroxymethyl)-5-isopropylphenyl)(isoindolin-2-yl)methanone × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.70 Å R-free 0.238
5UCI Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–218(218 aa) 片段:UNP residues 1-218
未记录 874 (2,4-Dihydroxy-3-(hydroxymethyl)-5-isopropylphenyl)(isoindolin-2-yl)methanone × 1 DMS DIMETHYL SULFOXIDE × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.70 Å R-free 0.238
5UCI Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–218(218 aa) 片段:UNP residues 1-218
未记录 874 (2,4-Dihydroxy-3-(hydroxymethyl)-5-isopropylphenyl)(isoindolin-2-yl)methanone × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.70 Å R-free 0.238
5UCI Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–218(218 aa) 片段:UNP residues 1-218
未记录 874 (2,4-Dihydroxy-3-(hydroxymethyl)-5-isopropylphenyl)(isoindolin-2-yl)methanone × 1 DMS DIMETHYL SULFOXIDE × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 2.70 Å R-free 0.238
5UCJ Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–218(218 aa) 片段:UNP residues 1-218
未记录 KU3 (5-fluoroisoindolin-2-yl)(4-hydroxy-5-isopropylbenzo[d]isoxazol-7-yl)methanone × 1 DMS DIMETHYL SULFOXIDE × 2 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 1.69 Å R-free 0.197
5UCJ Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–218(218 aa) 片段:UNP residues 1-218
未记录 KU3 (5-fluoroisoindolin-2-yl)(4-hydroxy-5-isopropylbenzo[d]isoxazol-7-yl)methanone × 1 DMS DIMETHYL SULFOXIDE × 2 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 1.69 Å R-free 0.197
5UCJ Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–218(218 aa) 片段:UNP residues 1-218
未记录 KU3 (5-fluoroisoindolin-2-yl)(4-hydroxy-5-isopropylbenzo[d]isoxazol-7-yl)methanone × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 1.69 Å R-free 0.197
5UCJ Hsp90b N-terminal domain with inhibitors 提交 2016-12-22 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–218(218 aa) 片段:UNP residues 1-218
未记录 KU3 (5-fluoroisoindolin-2-yl)(4-hydroxy-5-isopropylbenzo[d]isoxazol-7-yl)methanone × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;293 K;30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5
分辨率 1.69 Å R-free 0.197
6N8W Structure of Unliganded Hsp90-Beta N-Terminal Domain 提交 2018-11-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–231(231 aa)
未记录 GOL GLYCEROL × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;Tris-HCl pH 8.5, MgCl2, PEG 4000, Glycerol
分辨率 3.09 Å R-free 0.286
6N8W Structure of Unliganded Hsp90-Beta N-Terminal Domain 提交 2018-11-30 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–231(231 aa)
未记录 GOL GLYCEROL × 10 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;Tris-HCl pH 8.5, MgCl2, PEG 4000, Glycerol
分辨率 3.09 Å R-free 0.286
6N8W Structure of Unliganded Hsp90-Beta N-Terminal Domain 提交 2018-11-30 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–231(231 aa)
未记录 GOL GLYCEROL × 12 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;Tris-HCl pH 8.5, MgCl2, PEG 4000, Glycerol
分辨率 3.09 Å R-free 0.286
6N8W Structure of Unliganded Hsp90-Beta N-Terminal Domain 提交 2018-11-30 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–231(231 aa)
未记录 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;Tris-HCl pH 8.5, MgCl2, PEG 4000, Glycerol
分辨率 3.09 Å R-free 0.286
6N8Y Hsp90-beta bound to PU-11-trans 提交 2018-11-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–221(221 aa)
未记录 KFY 9-[(2E)-but-2-en-1-yl]-8-[(3,4,5-trimethoxyphenyl)methyl]-9H-purin-6-amine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;MES pH 6.5, MgCl2, PEG 2000 MME. Incubate with PU-11-trans prior to setup.
分辨率 1.55 Å R-free 0.183
7ULJ Hsp90b N-terminal domain in complex with 42C 提交 2022-04-05 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–218(218 aa)
未记录 42C N,N-dimethyl-7H-purin-6-amine × 1 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;0.1 M Sodium cacodylate pH 6.5, 0.1 M Sodium acetate, 5% MPD and 25% PEG8000
分辨率 1.82 Å R-free 0.219
7ULJ Hsp90b N-terminal domain in complex with 42C 提交 2022-04-05 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–218(218 aa)
未记录 42C N,N-dimethyl-7H-purin-6-amine × 1 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;0.1 M Sodium cacodylate pH 6.5, 0.1 M Sodium acetate, 5% MPD and 25% PEG8000
分辨率 1.82 Å R-free 0.219
7ULJ Hsp90b N-terminal domain in complex with 42C 提交 2022-04-05 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–218(218 aa)
未记录 42C N,N-dimethyl-7H-purin-6-amine × 1 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;0.1 M Sodium cacodylate pH 6.5, 0.1 M Sodium acetate, 5% MPD and 25% PEG8000
分辨率 1.82 Å R-free 0.219
7ULJ Hsp90b N-terminal domain in complex with 42C 提交 2022-04-05 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–218(218 aa)
未记录 42C N,N-dimethyl-7H-purin-6-amine × 1 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;0.1 M Sodium cacodylate pH 6.5, 0.1 M Sodium acetate, 5% MPD and 25% PEG8000
分辨率 1.82 Å R-free 0.219
7Z37 Structure of the RAF1-HSP90-CDC37 complex (RHC-II) 提交 2022-03-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 AP1 3–724(722 aa)
链 BP1 3–724(722 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE;blot for 3 seconds before plunging
分辨率 3.67 Å
7Z38 Structure of the RAF1-HSP90-CDC37 complex (RHC-I) 提交 2022-03-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 3–724(722 aa)
链 B 3–724(722 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 MG MAGNESIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE;blot for 3 seconds before plunging
分辨率 3.16 Å
7ZR0 CryoEM structure of HSP90-CDC37-BRAF(V600E) complex. 提交 2022-05-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
7ZR5 CryoEM structure of HSP90-CDC37-BRAF(V600E)-PP5(closed) complex 提交 2022-05-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.90 Å
7ZR6 CryoEM structure of HSP90-CDC37-BRAF(V600E)-PP5(open) complex 提交 2022-05-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.20 Å
7ZUB Cryo-EM structure of the indirubin-bound Hsp90-XAP2-AHR complex 提交 2022-05-12 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 2–724(723 aa)
链 B 2–724(723 aa)
未记录 ADP ADENOSINE-5'-DIPHOSPHATE × 2 MG MAGNESIUM ION × 2 MOO MOLYBDATE ION × 2 JY6 (3~{Z})-3-(3-oxidanylidene-1~{H}-indol-2-ylidene)-1~{H}-indol-2-one × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.85 Å
8EOA Cryo-EM structure of human HSP90B-AIPL1 complex 提交 2022-10-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 2–724(723 aa)
链 B 2–724(723 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5;25 mM HEPES, 200 mM NaCl, 1 mM TCEP, pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.90 Å
8EOB Cryo-EM structure of human HSP90B in the closed state 提交 2022-10-02 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–724(723 aa)
链 B 2–724(723 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5;25 mM HEPES, 200 mM NaCl, 1 mM TCEP, pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.10 Å
8GAE Hsp90 provides platform for CRaf dephosphorylation by PP5 提交 2023-02-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 K POTASSIUM ION × 2 MG MAGNESIUM ION × 2 ADP ADENOSINE-5'-DIPHOSPHATE × 1 ATP ADENOSINE-5'-TRIPHOSPHATE × 1 MN MANGANESE (II) ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE;3UL OF SAMPLE 10C 100% HUMIDITY 30S WAIT TIME 3S BLOT TIME -2 BLOT FORCE
分辨率 3.30 Å
8GFT Hsp90 provides platform for CRaf dephosphorylation by PP5 提交 2023-03-08 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 ADP ADENOSINE-5'-DIPHOSPHATE × 1 MG MAGNESIUM ION × 2 K POTASSIUM ION × 2 ATP ADENOSINE-5'-TRIPHOSPHATE × 1 MN MANGANESE (II) ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE;3uL OF SAMPLE, 10C, 100% HUMIDITY, 30S WAIT TIME, 3S BLOT TIME, -2 BLOT FORCE
分辨率 3.80 Å
8QMO Cryo-EM structure of the benzo[a]pyrene-bound Hsp90-XAP2-AHR complex 提交 2023-09-24 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 2–724(723 aa)
链 B 2–724(723 aa)
未记录 MOO MOLYBDATE ION × 2 ADP ADENOSINE-5'-DIPHOSPHATE × 2 MG MAGNESIUM ION × 2 W62 benzo[a]pyrene × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.76 Å
9D9H Human Hsp90b nucleotide binding domain in complex with BRI2311 提交 2024-08-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–223(223 aa) 片段:nucleotide binding domain
未记录 A1A26 (1P)-3-amino-6-[({1-[(2S)-2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]piperidin-4-yl}amino)methyl]-1-(4-phenyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)thieno[2,3-b]pyrazin-2(1H)-one × 1 CL CHLORIDE ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;21% PEG8000, 0.1M Hepes pH 7.5,1M LiCl
分辨率 1.96 Å R-free 0.208
9D9I Human Hsp90b nucleotide binding domain in complex with BRI2312 提交 2024-08-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–223(223 aa) 片段:nucleotide binding domain
未记录 A1A24 (1P)-3-amino-6-[({1-[(2R)-2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]piperidin-4-yl}amino)methyl]-1-(4-phenyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)thieno[2,3-b]pyrazin-2(1H)-one × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;21% PEG6000, 0.1M NaCacodylate pH 6.6, 1M Li
分辨率 1.50 Å R-free 0.187
9W5I AGO maturation complex (AMC): AGO2-miRNA duplex in complex with Hsp90 beta and co-chaperone p23 提交 2025-08-01 Assembly 1 蛋白–RNA 异源复合物;蛋白 × 4 PDB 声明:hexameric(6) 与全部聚合物一致
链 A 1–724(724 aa)
链 B 1–724(724 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 MG MAGNESIUM ION × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.63 Å